JPMorgan maintains Overweight on Bristol-Myers Squibb Co. (NYSE: BMY).Analyst Chris Schott says the overall results for Q3 were solid ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE